Project Grant HT94252310497
Award Date 6/1/23
Completion Date 5/31/25
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14263, USA
Similar Awards
- Health Research, Inc., operating as Health Research At Roswell Park, received a $1,152,194 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research aimed at leveraging infiltrating myeloid cells to improve therapeutic response to bispecific T-cell engaging (BiTE) antibody-secreting T cells in ovarian cancer treatment. This four-year initiative...
- Health Research, Inc. Inc Roswell Park Division Health Research Division (the Division) was awarded a $693,987 project grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The grant will fund cancer immunotherapy research from June 1, 2023 through May 31, 2026. Specifically, the Division will investigate strategies to counter solid tumor antigen immune escape using CAR T cell therapies. As a past recipient of Defense Health Agency...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $173,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The award supports research focused on improving chemotherapy efficacy for small cell carcinomas of the bladder, a rare cancer type with significant clinical relevance to military...
- The Defense Health Agency awarded a $168,200 Project Grant to Health Research, Inc. Roswell Park Division under the Military Medical Research and Development program (CFDA 12.420) to investigate alternative polyadenylation as a mediator of therapeutic resistance in lung cancer. The two-year award beginning July 1, 2021 will support research into innovative medical solutions for lung cancer treatment through the study of alternative polyadenylation, a novel area of investigation that could help...
- Federal Grant Award Summary Health Research, Inc. received a $958,389 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. As the Roswell Park Division of Health Research, the organization will conduct advanced biomedical research at its Buffalo, New York location. Based on the awardee's established portfolio, the research is expected to advance healthcare solutions...
- Federal Project Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $929,806 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bite-secreting T cells in ovarian cancer treatment. This research...
- This Project Grant award of $695,386.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Health Research, Inc. (Roswell Park Division) to investigate translation dysregulation in metastatic breast cancer. The project aims to evaluate the implications of this phenomenon for disease outcomes and immunotherapy responses. The award period runs from March 1, 2024 to February 28, 2027. As a prime grantee,...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park, received a $2.39M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, with a completion date of May 31, 2030. The project, titled "Stress, Lifestyle, and Immune Pathways in Aggressive Breast Cancer: An Epitranscriptomic Study," will be conducted at the organization's Buffalo, New York location....
- The U.S. Department of Defense's Defense Health Agency awarded Health Research, Inc. a $1,545,300 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING MYCAF-DRIVEN CASTRATION-RESISTANT PROSTATE TUMOR GROWTH." The award, which has a performance period of May 1, 2024 to April 30, 2027, will enable Health Research, Inc.'s Roswell Park Division to perform biomedical research and provide scientific services to advance...
- The Defense Health Agency awarded a $1,561,500 Project Grant to Health Research, Inc. Roswell Park Division for the period of March 15, 2023 through March 14, 2026. The grant will support research into slow-cycling prostate cancer cells in therapy resistance, disease relapse, and metastasis. This award is being made under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative medical research solutions for...